Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
AETERNA ZENTARIS Add to My Watchlist (NSDQ: AEZS) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Aeterna Zentar 0.82 - (+0.00%) 70,900
1405,du Parc-Technologique
Quebec, Quebec, G1P 4P5 CN
(418) 652-8525
(418) 652-0881 fax
www.aezsinc.com
CEO Dr. Jurgen Engel
Auditor PriceWaterhouseCoopers LLP
Exchange Traded NQ
ISIN Number CA0079752048
CIK Number 1113423
NAICS Code 325412
Business Summary
A global biopharmaceutical company, which is focused on endocrine therapy and oncology with expertise in drug discovery, development and commercialization, mainly targeting the North American and European markets.
Number of Employees 109
Share Fundamentals
Market Cap 51.73M
Shares Outstanding 63.09M
Float N/A
Short Interest 231.12K
Financial Strength
Revenue (TTM) $30,299,000
Earnings (TTM) -$51,249,000
Quick Ratio 2.4:1
Current Ratio 2.4:1
Total Debt/Equity 0:1
Profitability
Gross Margin 14.7%
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs